← Leaderboards
Gene P Siegal
University Of Alabama At Birmingham
$2,114,715
Attributed
$2,114,715
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $403.6K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,114,715 · 4
By mechanism
R01$1,450,500 · 3
P30$664,215 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- David T Curiel$31,690,411
- Majd Zayzafoon$4,514,421
- Selvarangan Ponnazhagan$11,274,357
- Joanne T Douglas$899,076
- Jeong S Hong$395,315
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyFlow CytometryHuman TissueMorphometryProteinsPolymerase Chain ReactionProgramsPreventTissuesResearch PersonnelCellsAthymic MouseGenesDisease /Disorder ModelNeoplasm /Cancer ImmunotherapyDesignAutopsyAutomationAnimalsArtsComplexEducational AspectsBone CellArea
Grant awards (12)
Histomorphometry and Molecular Analyses Core$177,954
P30 · FY2010 · AR · contact PI
Armed Replicating Ad for Breast Cancer Bone Metastasis$225,695
R01 · FY2009 · CA · contact PI
Histomorphometry and Molecular Analyses Core$177,954
P30 · FY2009 · AR · contact PI
Histomorphometry and Molecular Analyses Core$177,954
P30 · FY2008 · AR · contact PI
Histomorphometry and Molecular Analyses Core$130,353
P30 · FY2007 · AR · contact PI
Canine model for evaluating CRAD efficacy$313,850
R01 · FY2005 · CA
Canine model for evaluating CRAD efficacy$258,100
R01 · FY2004 · CA
Canine model for evaluating CRAD efficacy$258,100
R01 · FY2003 · CA
Canine model for evaluating CRAD efficacy$258,026
R01 · FY2002 · CA
Core-Histomorphometry and molecular analyses$0
P30 · FY2002 · AR
Core-Histomorphometry and molecular analyses$0
P30 · FY2001 · AR
SFV MEDIATED ONCOGENE KNOCKOUT FOR CHEMOSENSITIZATION$136,729
R01 · FY2000 · CA